The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B

References

• Rinella ME. Nonalcoholic fatty liver disease: a systemic review. JAMA. 2015;313(22):2263–2273. doi: 10.1001/jama.2015.5370.
   PubMed Web of Science ®Google Scholar
• Wong VW, Chitturi S, Wong GL, et al. Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. Lancet Gastroenterol Hepatol. 2016;1(1):56–67. doi: 10.1016/S2468-1253(16)30011-5.
   PubMed Web of Science ®Google Scholar
• Cook N, Geier A, Schmid A, et al. The patient perspectives on future therapeutic options in NASH and patient needs. Front Med . 2019;6:61. doi: 10.3389/fmed.2019.00061.
   PubMed Web of Science ®Google Scholar
• Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063–2072. doi: 10.1056/NEJMra1503519.
   PubMed Web of Science ®Google Scholar
• Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–873. doi: 10.1016/j.jhep.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099–2108. doi: 10.1002/hep.27406.
   PubMed Web of Science ®Google Scholar
• Huang Y, Gan Q, Lai R, et al. Application of fatty liver inhibition of progression algorithm and steatosis, activity, and fibrosis score to assess the impact of non-alcoholic fatty liver on untreated chronic hepatitis B patients. Front Cell Infect Microbiol. 2021;11:733348. doi: 10.3389/fcimb.2021.733348.
   PubMed Web of Science ®Google Scholar
• Choi HSJ, Brouwer WP, Zanjir WMR, et al. Nonalcoholic steatohepatitis is associated with liver-related out comes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71(2):539–548. doi: 10.1002/hep.30857.
   PubMed Web of Science ®Google Scholar
• Mota M, Banini BA, Cazanave SC, et al. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1049–1061. doi: 10.1016/j.metabol.2016.02.014.
   PubMed Web of Science ®Google Scholar
• Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26(9):1361–1367. doi: 10.1111/j.1440-1746.2011.06801.x.
   PubMed Web of Science ®Google Scholar
• Joo EJ, Chang Y, Yeom JS, et al. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology. 2017;65(3):828–835. doi: 10.1002/hep.28917.
   PubMed Web of Science ®Google Scholar
• Wang B, Li W, Fang H, et al. Hepatitis B virus infection is not associated with fatty liver disease: evidence from a cohort study and functional analysis. Mol Med Rep. 2019;19:320–326.
   PubMed Web of Science ®Google Scholar
• Chinese society of infectious diseases, chinese medical association; Chinese society of hepatology, Chinese medical association. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). Zhonghua Gan Zang Bing Za Zhi. 2019;27:938–961.
   PubMedGoogle Scholar
• Kleiner DE, Brunt EM, Van Natta M, et al. Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321. doi: 10.1002/hep.20701.
   PubMed Web of Science ®Google Scholar
• Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372–374. doi: 10.1016/0168-8278(91)90084-o.
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25–29. doi: 10.1038/75556.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–D361. doi: 10.1093/nar/gkw1092.
   PubMed Web of Science ®Google Scholar
• Tripathi S, Pohl MO, Zhou Y, et al. Meta- and orthogonal integration of influenza ‘OMICs’ data defines a role for UBR4 in virus budding. Cell Host Microbe. 2015;18(6):723–735. doi: 10.1016/j.chom.2015.11.002.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi: 10.1038/nmeth.3337.
   PubMed Web of Science ®Google Scholar
• Tong L. Acetyl-coenzyme a carboxylase: crucial metabolic enzyme and attractive target for drug discovery. CMLS, Cell. Mol. Life Sci. 2005;62(16):1784–1803. doi: 10.1007/s00018-005-5121-4.
   PubMed Web of Science ®Google Scholar
• Munday MR. Regulation of mammalian acetyl-CoA carboxylase. Biochem. Soc. Trans. 2002;30(6):1059–1064. doi: 10.1042/bst0301059.
   PubMedGoogle Scholar
• Fullerton MD, Galic S, Marcinko K, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med. 2013;19(12):1649–1654. doi: 10.1038/nm.3372.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Asano Y, Shintani Y, et al. Higd1a is a positive regulator of cytochrome c oxidase. Proc Natl Acad Sci U S A. 2015;112(5):1553–1558. doi: 10.1073/pnas.1419767112.
   PubMed Web of Science ®Google Scholar
• Li T, Xian WJ, Gao Y, et al. Higd1a protects cells from lipotoxicity under high-fat exposure. Oxid Med Cell Longev. 2019;2019:6051262. doi: 10.1155/2019/6051262.
   PubMed Web of Science ®Google Scholar
• Lee YI, Hwang JM, Im JH, et al. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem. 2004;279(15):15460–15471. doi: 10.1074/jbc.M309280200.
   PubMed Web of Science ®Google Scholar
• Masarone M, Rosato V, Dallio M, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2021;2021:9757921. doi: 10.1155/2018/9547613.
   PubMed Web of Science ®Google Scholar
• Ameri K, Jahangiri A, Rajah AM, et al. HIGD1A regulates oxygen consumption, ROS production, and AMPK activity during glucose deprivation to modulate cell survival and tumor growth. Cell Rep. 2015;10(6):891–899. doi: 10.1016/j.celrep.2015.01.020.
   PubMed Web of Science ®Google Scholar
• Ameri K, Maltepe E. HIGD1A-mediated dormancy and tumor survival. Mol Cell Oncol. 2015;2(4):e1030537. doi: 10.1080/23723556.2015.1030537.
   PubMedGoogle Scholar
• Jeon S-M, Chandel NS, Hay N, et al. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485(7400):661–665. doi: 10.1038/nature11066.
   PubMed Web of Science ®Google Scholar
• Zhu JY, Chen M, Mu WJ, et al. Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice. Metabolism. 2022;134:155241. doi: 10.1016/j.metabol.2022.155241.
   PubMed Web of Science ®Google Scholar